HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fredrik Ponten Selected Research

Pharmaceutical Preparations

4/2020Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis.
10/2017Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fredrik Ponten Research Topics

Disease

17Neoplasms (Cancer)
04/2020 - 08/2002
4Melanoma (Melanoma, Malignant)
01/2013 - 11/2008
3Glioma (Gliomas)
03/2014 - 01/2014
2Colorectal Neoplasms (Colorectal Cancer)
03/2020 - 01/2019
2Heart Failure
01/2016 - 01/2012
2Glioblastoma (Glioblastoma Multiforme)
03/2014 - 01/2014
2Lymphoma (Lymphomas)
01/2014 - 09/2011
1Colonic Neoplasms (Colon Cancer)
01/2019
1Squamous Cell Carcinoma of Head and Neck
10/2017
1Skin Neoplasms (Skin Cancer)
08/2016
1Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2016
1Microsatellite Instability
01/2015
1Astrocytoma (Pilocytic Astrocytoma)
03/2014
1Infections
01/2014
1Meningioma (Meningiomas)
01/2014
1Medulloblastoma
01/2014
1Inflammation (Inflammations)
10/2013
1Carotid Artery Diseases
10/2013
1Rupture
10/2013
1Heart Diseases (Heart Disease)
01/2012
1Lymphoid Leukemia
09/2011
1Multiple Myeloma
09/2011
1Prostatic Neoplasms (Prostate Cancer)
11/2010
1Diabetes Mellitus
06/2010
1Pigmented Nevus (Melanocytic Nevus)
04/2009
1Cutaneous Malignant Melanoma
11/2008
1Basal Cell Neoplasms (Basal Cell Cancer)
08/2002

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2017 - 06/2007
5Biomarkers (Surrogate Marker)IBA
01/2019 - 09/2010
3AntibodiesIBA
01/2014 - 11/2011
2Pharmaceutical PreparationsIBA
04/2020 - 10/2017
2MART-1 AntigenIBA
01/2013 - 11/2008
1Fluorouracil (Carac)FDA LinkGeneric
01/2019
1Cetuximab (Erbitux)FDA Link
10/2017
1ErbB Receptors (EGF Receptor)IBA
10/2017
1Gentian Violet (Violet, Crystal)FDA Link
10/2017
1Carrier Proteins (Binding Protein)IBA
08/2016
1Chromogranin AIBA
08/2016
1Coloring Agents (Dyes)IBA
08/2016
1SynaptophysinIBA
08/2016
1Formaldehyde (Formol)FDA Link
01/2016
1ParaffinIBA
01/2016
1Proteoglycans (Proteoglycan)IBA
06/2014
1DecorinIBA
06/2014
1Protein Isoforms (Isoforms)IBA
04/2014
1LigandsIBA
04/2014
1CateninsIBA
04/2014
1Kruppel-Like Factor 4IBA
03/2014
1Nanog Homeobox ProteinIBA
03/2014
1c-Mer Tyrosine KinaseIBA
02/2014
1Antiviral Agents (Antivirals)IBA
01/2014
1MitogensIBA
10/2013
1Peptide Hydrolases (Proteases)FDA Link
10/2013
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
10/2013
1Biological ProductsIBA
09/2012
1LIM Domain ProteinsIBA
01/2012
1EpitopesIBA
11/2011
1Glucose (Dextrose)FDA LinkGeneric
06/2010
1Blood Glucose (Blood Sugar)IBA
06/2010
1Galectin 1 (LGALS1)IBA
11/2008
1interferon tauIBA
11/2008

Therapy/Procedure

4Therapeutics
04/2020 - 04/2010
4Drug Therapy (Chemotherapy)
03/2020 - 01/2015
2Lasers (Laser)
06/2007 - 08/2002
1Immunotherapy
01/2019
1Adjuvant Chemotherapy
01/2019
1Precision Medicine
01/2017